Cargando…
Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
BACKGROUND: The primary objective of this study was to report the incidence of bloodstream infections (BSIs) and clinically or microbiologically proven bacterial or fungal BSIs during neutropenic episodes in patients with hematological malignancies. METHODS: In this retrospective observational study...
Autores principales: | Gedik, Habip, Şimşek, Funda, Kantürk, Arzu, Yildirmak, Taner, Arica, Deniz, Aydin, Demet, Demirel, Naciye, Yokuş, Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172031/ https://www.ncbi.nlm.nih.gov/pubmed/25258539 http://dx.doi.org/10.2147/TCRM.S68450 |
Ejemplares similares
-
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
por: Gedik, Habip, et al.
Publicado: (2014) -
Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?
por: Efe İris, Nur, et al.
Publicado: (2017) -
Community-acquired intracranial suppurative infections: A 15-year report
por: Yıldırmak, Taner, et al.
Publicado: (2014) -
Etiological causes of pancytopenia: A report of 137 cases
por: Yokuş, Osman, et al.
Publicado: (2016) -
Jak-2 mutation frequency in patients with thrombocytosis
por: Yokus, Osman, et al.
Publicado: (2018)